Patent AnalyticsExaminers
Menu

Application

18572348 · HETEROCYCLIC EGFR INHIBITORS FOR USE IN THE TREATMENT OF CANCER

Filed 2023-12-20 · Pending The official file ↗ · Art unit 1621 · Examiner David K O Dell Hard · CPC A61P 35/00 · Blueprint Medicines Corporation · MCCARTER & ENGLISH, LLP BOSTON

Office actions
1
first was Restriction requirement
RCEs
0
no appeal
To first action
26.1 mo
to disposition n/a
Statutes raised
103
1 actions read
Unlock the prosecution timelineIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in